quinoxalines has been researched along with glucagon-like peptide 1 (7-36)amide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradley, SJ; Coopman, K; Huang, Y; Johnston, N; Wilkinson, GF; Willars, GB | 1 |
| Li, N; Lu, J; Willars, GB | 1 |
2 other study(ies) available for quinoxalines and glucagon-like peptide 1 (7-36)amide
| Article | Year |
|---|---|
Comparative effects of the endogenous agonist glucagon-like peptide-1 (GLP-1)-(7-36) amide and the small-molecule ago-allosteric agent "compound 2" at the GLP-1 receptor.
Topics: Biotransformation; Calcium; Cell Line; Cell Membrane; Cell Survival; Cyclic AMP; Data Interpretation, Statistical; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Green Fluorescent Proteins; GTP-Binding Proteins; Humans; Ligands; Peptide Fragments; Quinoxalines; Receptors, Glucagon; Signal Transduction; Sulfones; Trypan Blue | 2010 |
Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor.
Topics: Adenosine Monophosphate; Allosteric Regulation; Animals; Biotransformation; Calcium; Calcium Signaling; Cell Line; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Insulin; Peptide Fragments; Peptides; Quinoxalines; Rats; Receptors, Glucagon; Sulfones; Transfection | 2012 |